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The burden of cardiovascular 
disease in sub-Saharan Africa
individuals surviving until middle and older age, when CVD 
becomes manifest – the so-called demographic transition. 
By 2025 it is estimated that the number of Africans over 
60 years old will increase from 39 million to 80 million.
2. Falling death rates from communicable diseases accompany 
socio-economic development, improved vaccination and other 
primary health care services. 
3. Socio-economic development results in changes in environmental 
and behavioural determinants of CVD, such as increasing 
tobacco use, increasing fat and calorie consumption, and 
physical inactivity. Longer periods of exposure to these 
determinants because of longer life expectancy increase the 
prevalence of CVD.
 
African countries are progressing through the epidemiological 
transition at a more rapid pace than occurred in Europe and 
America. This is partly due to rapid globalisation resulting in the 
“export of risk factors” such as tobacco, refi ned foods, and lifestyles 
with high CVD risk that are portrayed on television and fi lm.(5)
Furthermore different sectors of society within a country move 
through the transition at different rates.(6) In South Africa for 
example the white population is in stage IV; coloured and Indian 
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INTRODUCTION                                                            
Cardiovascular disease (CVD) is a growing cause of death and 
disability in South Africa and the rest of sub-Saharan Africa – partly 
as a result of the increasing prevalence of determinants and risk 
factors for CVD in these societies in transition. This process was 
dubbed “the epidemiological transition” by Omran:(1) a concept 
further developed by Olshansky(2) and Pearson.(3) The epidemio-
logical transition in turn, is predicated upon demographic and 
nutritional transitions occurring as a result of socio-economic 
development and increasing globalisation that alter the deter-
minants and risk factors for CVD and hence the patterns of CVD.
In most African countries CVD is now the second commonest 
cause of death after infectious disease, accounting for 10% of 
total deaths(4) and it is estimated that this burden of CVD will 
double from 1990 to 2020. 
THE EPIDEMIOLOGICAL TRANSITION           
The “epidemiological transition” comprises of four stages shown 
in Table 1.
Three main drivers fuel this epidemiological transition:
1. Declining infant and child mortality has lead to rapid demo-
graphic changes resulting in large increases in the number of 
The burden of cardiovascular disease (CVD) in Africa is 
growing and changing in nature. From the predominance of 
rheumatic heart disease and cardiomyopathies 50 years ago 
to hypertensive heart disease and haemorrhagic stroke in 
the past 25 years. Albeit at low prevalence, an increase in 
incidence of ischaemic heart disease is now being seen, 
particularly in urban areas. These changes in the extent and 
nature of CVD are thought to be the result of the so-called 
“epidemiological transition”. The challenge for health 
promotion and prevention is to accelerate the course of that 
transition and blunt its magnitude in order to avoid the 
massive epidemics of CVD that were seen in Europe and the 




















and middle class black Africans are in stage III; whilst the 70% of 
South Africans (mainly black African) who are poor or very poor 
are in stages I and II. The challenge for the next twenty years in 
South Africa is to ensure that the latter group, as they become 
progressively wealthier, do not enter stage III but pass rapidly 
through to stage IV. This can most effectively be achieved through 
health promotion including primary prevention, delivered at 
community and primary health care level, focussing on the 5 major 
risk factors for CVD of smoking, high blood pressure, bad diet 
(including high saturated and trans-saturated fats; as well as scanty 
fruit and vegetables), physical inactivity, and obesity.
African countries then face a double burden – of communicable 
diseases such as HIV and AIDS, TB and malaria; as well as CVD. 
The high levels of morbidity and premature mortality from CVD 
place a particular strain on African countries whose health systems 
are already struggling to cope with epidemics of infectious disease, 
perinatal and maternal disease.
The situation is exacerbated by the fact that CVD in Africa tends to 
occur earlier in life, resulting in socio-economic hardship as the 
breadwinner in the family dies or is disabled. In African countries 
more than half of CVD deaths occur among people between 
30 and 69 years of age, an age 5-10 years below the equivalent 
group in Europe and North America.(7)
Furthermore, their predicament is only likely to worsen, because 
the majority of their populations are under 35 years of age, and the 
determinants and risk factors for CVD are already prevalent and 
increasing within this age group.
Although the classical risk factors for CVD seem to operate in 
much the same way in all South African ethnic groups as they do in 
high income countries, their manifestations differ somewhat. For 
example, stroke supervenes at a younger age and haemorrhagic 
stroke is more common than thrombotic stroke.
Similar shifts in CVD pattern occurred in high income countries in 
the 1940s and 50s; but now low and middle income countries 
account for 82% of global mortality and 88% of mortality and 
morbidity from CVD.(4)
RHEUMATIC HEART DISEASE                                      
In the 1980s, most of sub-Saharan Africa was in stage I of the 
epidemiological transition; and rheumatic heart disease (RHD) 
accounted for 10% to 35% of hospital cardiac patients in sub-
Saharan Africa(8) and up to 20% of cardiac deaths noted at 
autopsy. In Soweto, Johannesburg, the incidence of RHD among 
primary school children was 6.9 per 1 000; and in Ibadan, Nigeria, 
the incidence was 3 per 1 000 among children.(8)  This is particularly 
tragic as RHD is completely preventable having been virtually 
eradicated in most high income countries over the past 50 years. 
It is a disease of poverty, related to overcrowding, poor housing, 
and undernutrition and requires a multi-sectoral response for 
prevention and cure. It is caused by group A beta-haemolytic 
streptococci. The principal methods of control are primary and 
secondary prevention of streptococcal infection.
FETAL ORIGINS OF CARDIOVASCULAR DISEASE   
Formerly CVD was seen as a disease of affl uence; but the 
reverse is in fact true. Poor socio-economic conditions in child-
TABLE 1:  Epidemiological transition
Phase of epidemiologic transition  Details from circulatory disease (%) Circulatory problems Risk factors 
Age of pestilence and famine 5 - 10 Rheumatic heart disease, infection and Uncontrolled infection, defi ciency  
  defi ciency-induced cardiomyopathy conditions
Age of receding pandemics 10 - 35 As above, plus hypertensive heart High-salt diet leading to hypertension, 
  disease and hemorrhagic stroke increased smoking
Age of degenerative and  35 - 55 All forms of stroke, ischaemic heart Atherosclerosis from fatty diets,  
man-made diseases  disease sedentary lifestyle, smoking
Age of delayed degenerative diseases Below 50 Stroke and ischaemic heart disease Education and behavioural changes 
  at older ages leading to lower levels of risk factors
Pearson et al. 1993, 8 based on Omran 1971, 3 and Olshansky and Ault 1986
6hood determine CVD in middle age as strongly as do CVD 
risk factors in middle age in the same individuals.(9) Furthermore, 
in humans, birth size serves as a marker of the intrauterine 
environment. In 1995 David Barker wrote: “The fetal origins 
hypothesis states that fetal undernutrition in middle to late 
gestation, which leads to disproportionate fetal growth, pro-
grammes later coronary heart disease” and hypertension.(10) 
The highest risk of coronary heart disease is seen among indivi-
duals who were born small and became heavier during child-
hood,(11) so-called “catch-up growth”.
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE   
IN AFRICA
Epidemiological data on CVD in Africa is scanty and of poor quality 
and national vital registration is available in only 5% of Africa’s 
53 countries.(12) Verbal autopsy has been shown to be an eco-
nomical and useful way of improving the quality of cause-of-death 
information when health workers have minimal training.(12) 
Sentinel surveillance has also proven useful in monitoring changes 
in CVD prevalence with disease surveys periodically conducted at 
sentinel sites that are broadly representative of the general 
population. Demographic health surveys are conducted in several 
African countries including South Africa.(13)
 The importance of CVD mortality in sub-Saharan African countries 
tends to be underestimated, because crude mortality rates are 
used. Age-standardised mortality ratios (Table 2) however, reveal 
that several African countries are in the throes of an epidemic of 
CVD – where those who survive infant deaths and infectious 
disease in young adulthood – proceed to experience mortality 
rates in middle and later life that are sometimes higher than for 
Scotland and Finland.(14)
CORONARY HEART DISEASE                                                                 
The prevalence of CVD continued to rise through the 1980s 
becoming the third most common cause of death in a prospective 
autopsy study in 90 of the 167 deaths in one year at Tshepong 
Hospital in the North West province of South Africa.(15) Of these 
CVD deaths, 32% were cerebrovascular events, (intracerebral 
hemorrhage in 50%, cerebral infarction in 29%); pulmonary 
hypertension in 31%; dilated cardiomyopathy 17%; chronic 
rheumatic valvular disease 17%; and hypertensive heart disease 
14%. Only 3% of the examined vessels had signs of severe 
atherosclerosis. 
Even as late as 1997, coronary artery disease ranked only eighth 
among the CVD registered in Cameroon with a prevalence of 
1.53%. However, risk factors for coronary disease were 
common amongst those with coronary disease in this 5-year 
prospective study with obesity occurring in 80%, hypertension 
in 60%, dyslipidaemia in 43%, smoking in 36% and diabetes/
hyperglycaemia in 26%. Seventy six percent of the patients had 
at least 3 cardiovascular risk factors.(16)
In South Africa coronary disease is the major cause of death among 
white people and South Africans of Indian descent, with incidence 
rates of 165.3 and 101.2 per 100 000 people respectively, 
but only 55.1 per 100 000 among people of mixed descent and 
5.3 per 100 000 among black African people. Cerebrovascular 
disease is the commonest cause of CVD death among those of 
mixed descent, followed by white people and South Africans of 
Indian descent, and then black African people (73.6, 62.5, and 
36.5 per 100 000, respectively).(14)
The increase in coronary heart disease (CHD) in sub-Saharan 
Africa is presumably because of the increasing prevalence among 
African populations of the classical risk factors for CHD: smoking, 
a diet high in saturated fat, hypertension, obesity, diabetes mellitus, 
and lack of physical exercise. In addition, life expectancy in sub-
Saharan Africa has risen so that more people are exposed to 
these risk factors for long enough periods to cause CHD. A study 
of black African patients admitted to a coronary care unit with 
acute myocardial infarction between 1995 and 1996 showed high 
rates of smoking and hypertension among the patients compared 
with controls matched by age and sex.(17)  
TABLE 2:  Age-standardised death rates per 100 000 in the year 2000
Comparative risk factor assessment, 2006 Bradshaw et al. MRC 
 Black  White  Coloured  SA of  South  
 African    Indian  Africa 
    descent
All Causes  1 613  937  1 304  1 172  1 468
Cardiovascular  375  384  406  607  361
diseases




















In patients with newly diagnosed cardiovascular disease (CVD) 
presenting to a tertiary-care centre (Chris Hani Baragwanath 
Hospital in Soweto, South Africa) the most common conditions 
among these patients were hypertension, heart failure, valvular 
heart disease, and coronary artery disease.(7) Artherosclerotic risk 
factors were widely prevalent, only 13% of patients had no risk 
factors at all. Furthermore, a substantial proportion of patients 
presented at an advanced stage of disease. 
A coronary angiographic study of black African patients with acute 
myocardial infarction and acute ischaemic syndromes admitted to 
Chris Hani Baragwanath Hospital in Johannesburg, South Africa 
showed a clear increase in prevalence of risk factors for CHD in 
these patients compared with age- and sex-matched controls.(18) 
STROKE                                                                            
Stroke is probably the commonest form of CVD in sub-Saharan 
Africa today, having increased in the latter half of the twentieth 
century as a result of increased life expectancy and changes in 
environmental determinants and risk factors. The majority of strokes 
occur in young and middle-aged people and are related to 
hypertension. Stroke accounted for 5% of deaths in South Africa 
in 2006.(19) Though the number of reported stroke deaths has 
more than doubled since 1995 (reaching 34 926 deaths in 2006), 
the actual proportion of total deaths has fallen from 6.6% in 1995 
to 4.6% in 2006 of total deaths due to the tripling of number 
of deaths largely due to HIV and AIDS and tuberculosis.
HYPERTENSION                                                   
Hypertension is highly prevalent in sub-Saharan Africa (12% 
amongst adults in the SADHS of 2002) and is often undetected 
or poorly controlled. This may be the explanation for the high 
proportion of hemorrhagic cerebrovascular accidents (CVAs), 
whereas in developed countries most CVAs occur in older people 
and are thrombotic in etiology. 
Systemic hypertension is the commonest cause of heart failure 
among black Africans. Early detection and control of systemic 
hypertension should be more aggressively pursued.(7)
The global INTERHEART study demonstrated that nine easily 
measured risk factors are associated with more than 90% of 
the risk of myocardial infarction.(20)
DILATED CARDIOMYOPATHY                                         
Dilated cardiomyopathy (DCM) resulting in congestive cardiac 
failure is surprisingly common in sub-Saharan Africa, accounting for 
up to 20% of cardiac cases in some regions. Occasionally the 
disease is familial with specifi c candidate genes recently identifi ed.(21) 
There may be a whole spectrum of causes of DCM, including 
genetic etiology, toxins, and vitamin or micronutrient defi ciency, 
such as selenium defi ciency. Dilated cardiomyopathy is often seen 
as a late complication of HIV infection.(22) 
ENDOMYOCARDIAL FIBROSIS                                       
Endomyocardial fi brosis is the most common restrictive 
cardiomyopathy worldwide.(23) It has no specifi c treatment and 
carries a poor prognosis, since most patients present with advanced 
heart failure. It involves fi brosis of the infl ow tracts of the right 
and left ventricles resulting in mitral or tricuspid  incompetence; 
and impaired ventricular function, as a result of the restrictive defi cit 
in which the stiff fi brotic ventricles cannot contract and relax 
normally. Patients usually present in their twenties or thirties. 
On the basis of clinical series, regional variations in distribution have 
been reported within several countries in Africa between the 
Sahara Desert in the north and the Zambezi River in the south; 
as well as in Asia and South America, but large-scale data on the 
epidemiologic features and early stages of the disease only recently 
became available.(24) Mocumbi et al using transthoracic echo-
cardiography to determine the prevalence of endomyocardial 
fi brosis in a rural area of Mozambique, estimated overall prevalence 
of endomyocardial fi brosis at 19.8%.  The prevalence was highest 
among persons 10 to 19 years of age (28.1%); and was higher 
among male than among female subjects (23.0% vs. 17.5%, P=0.03). 
The most common form was biventricular endomyocardial fi brosis 
(56%), followed by right-sided endomyocardial fi brosis (28%). The 
frequency of familial occurrence was high and 77% of cases were 
asymptomatic.  
In temperate climates the disease is rare, presenting as Loeffl er’s 
endocarditis, a syndrome with marked eosinophilia. Consequently it 
has been suggested that EMF may be caused by an eosinophilic 
response to fi lariasis or malaria.(8)
8HIV DISEASE AND THE HEART                                    
It is now evident that cardiac involvement in patients with HIV and 
AIDS is relatively common. The effects occur in three ways: by 
direct invasion;(25) through the effects of opportunistic infections 
as a result of AIDS; and as side-effects of the treatment of HIV 
disease with antiretrovirals, particularly due to the longer survival 
of patients infected with HIV. 
People living with HIV and AIDS have evidence of cardiac 
involvement at post mortem (40%) and by echocardiography 
(25%).(22) However, fewer than 10% ever experience symptoms. 
Cardiac involvement is the cause of death in only 1% to 2% of 
patients infected with HIV(24) but this may change as hundreds 
of thousands of Africans are initiated onto antiretroviral therapy, 
particularly protease inhibitors. 
Dilated cardiomyopathy is a late manifestation of HIV disease and 
the mechanism may include myocarditis due to HIV itself or the 
defi ciencies of carnitine, selenium and thiamine that supervene 
in AIDS. This may therefore be exacerbated in Africa where 
malnutrition is already rife. Cardiotoxicity of some drugs such as 
zidovudine has also been described.  
Coronary disease may occur as a result of the dyslipidaemia, 
glucose intolerance, increased levels of C peptide, and endothelial 
dysfunction associated with some antiretroviral drugs, particularly 
protease inhibitors and nucleoside reverse transcriptase inhibitors. 
The incidence of diabetes is increased 3-fold in those on HAART. 
The vessel involvement is frequently diffuse and circumferential 
along the whole artery.(25) Other mechanisms may include altered 
coagulation in HIV disease, as well as changed adhesion properties 
of vascular monocytes. Coronary event incidence rates of 5.5 per 
1 000 patient-years in patients receiving HAART have been 
reported.(25)  Myocardial infarction is the mode of presentation in 
up to 76% and cebrovascular events are also common.(25) 
HIV and AIDS also cause stroke, pulmonary embolism, tuber-
culous pericarditis, marantic (non-bacterial) endocarditis, auto-
nomic dysfunction, and proarrhythmic drug effects. In a recent 
review of 17 peer-reviewed publications covering January 1980 
to February 2003 on cardiac involvement in HIV-infected people 
living in Africa, Magula and Mayosi(26) confi rmed that cardiac 
abnormalities are more common in HIV-infected people than in 
normal controls and that about half of hospitalised patients and 
a signifi cant proportion of patients followed over several years 
develops cardiac abnormalities. 
The most common HIV-related cardiac abnormalities are 
cardiomyopathy (in 20% before the advent of HAART), and 
pericardial disease (in 20% of patients). Tuberculosis is the major 
cause of large pericardial effusion in Africa. HIV-related pericardial 
effusions are usually exudates and tend to occur in patients with 
advanced disease, with an annual incidence of 10%.  They are an 
independent risk factor for early death, with mortality at six 
months of 62% in those with effusions compared to 7% in those 
without.(24)
Infective endocarditis is also common in HIV disease; though with 
the introduction of HAART the incidence declined from 20.6 to 
6.6 per 1 000 patient years.(25)
Patients living with HIV and AIDS may also suffer from the cardiac 
effects of the malignancies that commonly occur in AIDS, such as 
Kaposi’ sarcoma and Hodgkin’s lymphoma.
The prevalence of hypertension is increased 3-fold in patients 
on HAART(25) and the prevalence of pulmonary hyper-tension 
increased from 1 in 200 000 in the general population to 1 
in 200.(25)  
CONGENITAL HEART DISEASE                                      
Children in Africa suffer from rheumatic heart disease and sickle-
cell. Congenital heart disease has prevalence of 2.0 per 1 000, 
with ventricular septal defect, atrial septal defect, patent ductus 
arteriosus, and Fallot’s tetralogy making up 85% of the cases.(28) 
DYSRHYTHMIAS                                                               
Atrial fi brillation is the most common cardiac arrhythmia in South 
Africa, with an incidence of about 8% of the population 




















70 years and older. In a cardiac clinic in Soweto, South Africa 
33% of patients had some form of arrhythmia; and 7% had 
atrial fi brillation.(7)
PERICARDIAL EFFUSIONS                                              
A study carried out from 1989 to 1996 in the Republic of Congo 
found that 4.9% of patients with cardiovascular disease had 
nonrheumatic pericarditis with effusion.(28) Twenty-two percent 
were HIV positive. The principal cause of the pericarditis was 
tuberculosis, which accounted for about a quarter of the patients, 
all of whom were HIV positive.  
URBAN RURAL DIFFERENCES                                     
At the beginning of the twentieth century, high blood pressure was 
virtually nonexistent among indigenous Kenyans(29) and Ugandans,(8) 
but the reason may have been the lack of screening programs and 
access to care. From about 1975, high blood pressure became 
established, especially in urban centres. Rural-to-urban migration 
coupled with acculturation and modernisation trends have some 
relation to the development of high blood pressure, whose 
prevalence varies from 5% amongst rural African cohorts to 15% 
in urban areas.(30,31)
Among the Luo of Kenya, increasing blood pressure within months 
of migrating from the rural areas to the city has been recorded, 
with concomitant increases in their dietary sodium and declines in 
their dietary potassium.(29) 
In South Africa, even rural populations have high rates of non-
communicable disease, which accounted for 41% of deaths in those 
aged 50 and older in a rural demographic site in the eastern part of 
South Africa.(33)
CONCLUSION                                                                 
To date no evidence has been found that Africans have esoteric, 
genetically determined risk factors for CVD that differ from other 
populations in the world; nor do they appear to have special 
genetic traits that protect them from heart disease. It seems likely 
that the continuing socio-economic advance in many African 
countries over the next 50 years will be accompanied by the 
attendant increases in CVD that were  seen in epidemiological 
transitions across the world over the past 50 years. 
CHD and strokes share common determinants and risk factors 
and are more common in urban than rural areas. Any suggestion 
that people of black African descent are in some way immune 
from CVD has been dispelled by well-documented evidence from, 
among other countries, Cameroon, Caribbean countries, Mauritius, 
the Seychelles, South Africa, Tanzania, and the United States. In 
such countries CVD already accounts for between 15% and 40% 
of all deaths.
The challenge is to introduce primary and secondary prevention 
measures now, before the epidemic of CVD accelerates, parti-
cularly as such strategies may be more cost-effective than angio-
plasty and cardiac surgery in the cash-strapped economies of 
sub-Saharan Africa.
The costs of intersectoral, primary preventive measures to control 
CVD are likely to be much lower than those for acute, secondary 
care. As an example, the cost-effectiveness of introducing anti-
tobacco legislation, and limiting the quantities of salt permitted in 
processed food. Such health promotion interventions should be 
coupled with primary health care systems delivering secondary 
prevention, treatment and care for CVD. 
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